Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Industry Alliance Platform Trial to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients

NCT04590586 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT04590586
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04590586 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Industry Alliance Platform Trial to Assess the Efficacy and Safety of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients
Lead sponsor
Amgen
Phase
Phase 3
Overall status
Completed
Start date
November 24, 2020
Completion date
August 3, 2021
Enrollment
515 (actual)
Sites
59

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19